Fact CheckerSign in

NCT06411561Recruiting

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after hospital discharge. Older ICU survivors (ages 60 and older) are at highest risk for delirium and subsequent cognitive impairment, which contribute to higher risk for cognitive decline related to Alzheimer's disease and related dementias. Sleep and activity are essential for recovery from critical illness, yet ICU survivors experience both sleep deficiency and profound inactivity. About 75-80% of ICU patients experience circadian dysrhythmia, which contributes to cognitive decline and increases likelihood of developing Alzheimer's disease and related dementias. The scientific premises of the proposed study are: 1) a combined sleep promotion and cognitive training intervention will have synergistic effects to mitigate the risk of cognitive impairment and development of Alzheimer's disease and related dementias in older ICU survivors; and 2) chronotherapeutic timing of interventions (i.e., adjusting timing of interventions according to circadian rhythm) may improve intervention efficacy.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
11 Apr 2024
Start date
26 Dec 2024
Primary completion date
31 May 2027
Lead sponsor
University of Washington
NCT number
NCT06411561

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 26 Dec 2024 to the primary completion date, 31 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Documented history or suspicion of Alzheimer's disease or dementia, or current prescription of anti-dementia medication
  • Documented history of bipolar disorder or schizophrenia
  • Documented acute stroke or traumatic brain injury
  • Severe vision impairment
  • Severe hearing impairment

Other

  • Severe paralysis or dominant arm paresis
  • Transfer from skilled nursing care facility or inpatient rehabilitation facility

Who the study is looking for

  • Age greater than or equal to 60 years old
  • Current hospitalization at University of Washington Medical Center or Harborview Medical Center
  • Intensive care unit (ICU) length of stay greater than 24 hours
  • Recovery from critical care status to acute care status, and/or discharge out of ICU
  • Fluent in English or Spanish
  • Functional independence on activities of daily living prior to hospitalization (Katz Index = 6)

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Washington
Coordinator of this site? Confirm its status
SeattleUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.